Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects

NCT00908271 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Dapagliflozin

Sponsor

AstraZeneca

Collaborators

[object Object]